Keyphrases
Alzheimer's Disease
79%
APOE4
38%
Alzheimer's Disease Model
33%
Synapse
31%
Amyloid beta
22%
Synaptic
19%
Neurodegeneration
18%
Apolipoprotein E
17%
Alzheimer's Disease Patient
16%
Astrocytes
16%
Synaptic Dysfunction
14%
Amyloid Precursor Protein
14%
APOE2
12%
Mouse Model
11%
Neuroinflammation
11%
Synapse Loss
11%
Human Brain
10%
Amyloid Plaques
10%
Human tau
10%
Synaptic Function
10%
Genetic Risk
10%
Microglia
9%
Amyloid Accumulation
9%
Amyloid Deposition
9%
Alzheimer
8%
Postmortem Brain
8%
Normal Aging
8%
Comparative Profiling
8%
Clusterin
8%
APOE Genotype
8%
Tau Deposition
8%
Brain Analysis
8%
Extending Lifetime
8%
Synapse Proteome
8%
Lothian Birth Cohort
8%
Tau Levels
8%
Transmembrane Protein 97
8%
APOE Alleles
8%
Input Ratio
8%
Polypill
8%
Plaque Size
8%
Iatrogenic CJD
8%
Human Growth Hormone
8%
Dysregulation
8%
Antisense Oligonucleotides
8%
Primary Hippocampal Neurons
8%
Brain-inspired
8%
Tauopathy Model
8%
Ca2+ Homeostasis
8%
Age-related Illnesses
8%
Neuroscience
Alzheimer's Disease
100%
Synapse
48%
Amyloid Protein
41%
Neurodegeneration
18%
Apolipoprotein E
17%
Apolipoprotein E4
16%
Astrocyte
16%
Amyloid Precursor Protein
16%
Beta Amyloid
14%
Tauopathy
11%
Microglia
10%
Blood Brain Barrier
9%
Clusterin
8%
Progressive Supranuclear Palsy
8%
Beta Adrenergic Receptor
8%
Transmembrane Protein
8%
Transcriptome
8%
Synaptic Potential
8%
Cognitive Disorders
8%
CREB1
8%
Oligomer
8%
Proteome
8%
Human Growth Hormone
8%
Antisense Oligonucleotide
8%
Synaptic Vesicle
8%
Creutzfeldt Jakob Disease
8%
Senile Plaque
6%
Biochemistry, Genetics and Molecular Biology
Synapse
36%
Amyloid Protein
22%
Apolipoprotein
17%
Amyloid Precursor Protein
16%
Allele
14%
Tau
14%
Apolipoprotein E
14%
Mouse Model
13%
Amyloid Beta
13%
Genotyping
11%
Lifespan
9%
Genetic Risk
8%
Bovine Somatotropin
8%
Clusterin
8%
Homeostasis
8%
CREB1
8%
Oligonucleotide
8%
Gene Therapy
8%
Antisense
8%
Growth Hormone
8%
Proteome
8%
Creutzfeldt-Jakob Disease
8%
Genetics
5%
